En español
NIDA

Menu

Former DISCA Awardee and Colleagues Report Changes in Mexican Controls Reduced Methamphetamine Potency, Harm in United States

Former NIDA International Program Distinguished International Scientist Octavio Campollo, M.D., M.Sci., Ph.D., Mexico, and colleagues report in Drug and Alcohol Dependence that Mexico’s 2004 controls on ephedrine and pseudoephedrine changed the U.S. methamphetamine market. Restrictions on these precursor chemicals in Mexico resulted in widespread emergence of less potent methamphetamine and declines in prevalence and availability of the most potent type of the drug, which had dominated the U.S. market since the late 1980s. The authors found that U.S. methamphetamine treatment admissions declined between 2005 and 2010 and suggest that the emergence of less potent methamphetamine may have helped limit dependence. (Cunningham JK, et al. Mexico’s precursor chemical controls: Emergence of less potent types of methamphetamine in the United States. Drug Alcohol Depend. 2013 Apr 1;129(1–2):125–36. doi: 10.1016/j.drugalcdep.2012.10.001) PubMed abstract.

This page was last updated April 2013

Get this Publication

    Important Dates

    NIDA International Program Fellowships

    Application Deadlines:
    Postdoctoral Fellowships:
    April 1

    Meetings

    October 2 - October 6, 2014
    Yokohama, Japan
    October 18 - October 21, 2014
    Berlin, Germany
    November 15 - November 19, 2014
    Washington, DC, USA